ArticleBMJ open2026

Prevent 6:1 trial: pI rotocol for a feasibility trial of a 6:1 intermittent diet for weight gain prevention in women at increased risk of breast cancer.

Laura Kinsey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.